Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

US Government Launches Microbiome Research Initiative

XTALKS VITALS NEWS

Microbiome

Researchers have been increasingly identifying links between the microbiome and chronic diseases, including diabetes, asthma and obesity.

Share this!

May 16, 2016 | by Sarah Massey, M.Sc.

On Friday, the White House announced it would be funding a new public-private microbiome research fund, aimed at supporting the development of new therapies promoting healthy bacterial communities. The National Microbiome Initiative (NMI), will be overseen by the Science and Technology Policy group, along with other federal agencies and private companies.

The goal of the initiative is to “foster the integrated study of microbiomes across different ecosystems.” The NMI will be launched with over $121 million in funding for its first year of microbiome studies in human health and agriculture.

Microbiomes are composed of a variety of microorganisms which live in the body, the soil, the oceans, and even the atmosphere. They play a vital role in maintaining the health of humans, animals and the environment.



Researchers have been increasingly identifying links between the microbiome and chronic diseases, including diabetes, asthma and obesity. A better understanding of these microbial communities could lead to the development of new microbiome-targeted medicines.

“The NMI aims to advance understanding of microbiome behavior and enable protection and restoration of healthy microbiome function,” said a statement released by the White House. “In a year-long fact-finding process, scientists from Federal agencies, academia, and the private sector converged on three recommended areas of focus for microbiome science, which are now the goals of the NMI.”

The current goals of the project include developing platform technologies, supporting interdisciplinary research and expanding the workforce of the microbiome project. The Department of Energy, the National Institutes of Health (NIH) and the National Science Foundation are all chipping in to support the initiative.


Keywords: Microbiome, Chronic Disease, NIH


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
New Self-Injectable Form of Lupus Drug Approved by the FDA

July 25, 2017 - Patients with systemic lupus erythematosus (SLE) will now have the option to self-inject their medication thanks to the FDA approval of GSK’s reformulated lupus drug, Benlysta (belimumab).

Featured In: Biotech News


Canadian Chicken Farmers to Further Reduce Use of Antibiotics

July 24, 2017 - The Chicken Farmers of Canada, a national group dedicated to supporting poultry farmers and helping them meet consumer demand for chicken, has announced their strategy for eliminating the use of certain antimicrobials in meat production.

Featured In: Food News


Neonatal MRI Medical Device Approved by the FDA

July 24, 2017 - Medical device maker Aspect Imaging has received US Food and Drug Administration (FDA) approval for its Embrace Neonatal MRI System.

Featured In: Medical Device News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Top 5 Most Impactful Tweets from #AAIC17

REGISTER FOR THESE WEBINARS

Into the Great Wide Open: PTC’s Transformation & Global Journey to Bring Patients a First Ever Rare Disease Therapy


EDC and eSource: Combined for Better Data and Faster Insights


Using Model Reduction to Bridge the Quality Systems Pharmacology-Pharmacometrics Divide


How to Maximize Your Non-GLP Toxicology Studies: A Guide for Optimal Design and Methodology


Copyright © 2016-2017 Honeycomb Worldwide Inc.